無料プレビュー

Guardant Health, Inc. (GH) · NASDAQ Global Select

プロフィール

Guardant Health is a precision oncology company providing blood and tissue diagnostic tests for cancer detection, monitoring, and treatment selection. The company offers Guardant360 CDx and Guardant Reveal for therapy guidance and minimal residual disease detection, Guardant360 Tissue for tumor profiling, and Shield for colorectal cancer screening. Guardant Health serves oncologists and primary care physicians through a U.S. sales organization and biopharmaceutical companies through clinical research partnerships, with international expansion through regional partnerships.

主要指標

株価: $165.56 (-1.65%)
時価総額: 222億ドル
PER（今期予想）: -50.9
PBR: -98.1
配当利回り: —
52週レンジ: $61.00 – $191.05
業種: Healthcare / Medical - Diagnostics & Research
上場: NASDAQ Global Select
構成銘柄: —

比較会社: TMO Thermo Fisher Scientific Inc.、DHR Danaher Corporation、NTRA Natera, Inc.、A Agilent Technologies, Inc.、IQV IQVIA Holdings Inc.、WAT Waters Corporation、IDXX IDEXX Laboratories, Inc.、ILMN Illumina, Inc.

長期トレンド・直近動向・強気／弱気シナリオ・業績10年・バリュエーション・テクニカル・株主・役員・深掘り分析は会員向けです。

7日間無料で全文を読むログイン

次回決算: 2026-10-28 · 更新: 2026-10-09